Published TCIMAIL newest issue No.200 | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2025 | [Product Highlights] Cell Culture-Ready Antibiotic... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 127-07-1 | 產品號碼: H0310
| 產品號碼 | H0310 |
純度/分析方法 
|
>97.0%(HPLC)(N) |
| 分子式 / 分子量 | CH__4N__2O__2 = 76.06 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
| 儲存在惰性氣體下 | Store under inert gas |
| 應避免的情況 | Hygroscopic |
| CAS RN | 127-07-1 |
| Reaxys-RN | 1741548 |
| PubChem Substance ID | 87570732 |
| SDBS (AIST Spectral DB) | 3920 |
| Merck Index(14) | 4848 |
| MDL編號 | MFCD00007943 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(with Total Nitrogen) | min. 97.0 % |
| NMR | confirm to structure |
性質
| 熔點 | 140 °C |
GHS
| 圖形表示 |
|
| 信號詞 | Danger |
| 危險性說明 | H361 : Suspected of damaging fertility or the unborn child. H340 : May cause genetic defects. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
相關法規
| RTECS # | YT4900000 |
運輸資料
| UN編號 | UN2811 |
| 類別 | 6.1 |
| 包裝類別 | III |
| HS編碼* | 2928.00-000 |
Application
Adeno-associated virus vector transduction enhancer
Hydroxyurea increases transduction by adeno-associated virus (AAV) vectors.1)
References
- 1) DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectors
Application
Hydroxyurea (or hydroxycarbamide): A Ribonucleotide Reductase Inhibitor
Hydroxyurea (or hydroxycarbamide), a hydroxylated molecule of urea [U0077][U0073], is classified as an antitumor antimetabolite. Hydroxyurea inhibits deoxynucleotide and DNA synthesis by blocking the cellular enzyme ribonucleotide reductase, which is responsible for producing the deoxynucleotides required for DNA synthesis and repair, producing cell death in S phase (the phase of DNA synthesis). Recently, two effects of hydroxyurea have been reported: hydroxyurea increases the level of fetal hemoglobin, leading to a reduction in the incidence of vaso-occlusive crises in sickle cell anemia, and hydroxyurea inhibits human immunodeficiency virus-type 1 (HIV-1) DNA synthesis. (The product is for research purpose only.)
References
- Mechanism of action of hydroxyurea (a review)
- Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide
- Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication
- Pharmacokinetics and pharmacodynamics of hydroxyurea (a review)
- Nitric oxide production from hydroxyurea (a review)
- Colorimetric determination of hydroxyurea in human serum using high-performance liquid chromatography
PubMed Literature
文檔
產品介紹報導
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。